LeMaitre Vascular, Inc. Q4 2008 Sales Up 9% to $12.1 Million; Op. Profit of $354,000; Termination of the AlboGraft Distribution Agreement with Edwards Lifesciences

BURLINGTON, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NasdaqGM:LMAT - News), a provider of peripheral vascular devices and implants, today announced Q4 and full year 2008 financial results. The Company also announced it has entered into a definitive agreement with Edwards Lifesciences to terminate their distribution of the Company’s AlboGraft polyester grafts.